04 May 2020
REMDESIVIR: GILEAD IS DONATING ITS SUPPLY, BUT WHAT’S A FAIR PRICE?
How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures. While Gilead has yet to present a marketing plan for the first coronavirus treatment to have shown clinical benefits in a well-designed randomized study, the Institute for Clinical and